## Abstract ## BACKGROUND Black/African American men die of prostate cancer at a greater rate relative to other males. During the period from 1992 to 1998, prostate cancer incidence rates in the United States were 234.2 per 100,000 persons among nonβHispanic black males and 144.6 per 100,000 perso
Successful strategies for recruiting African Americans to prevention trials
β Scribed by Donna H. Ryan; Betty M. Kennedy; Lisa L. Smith; Elizabeth W. Tucker; Lee E. Melancon; Ben H. Phillips; Claire C. Lassale; George A. Bray
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 79 KB
- Volume
- 83
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
In 1992, the Pennington Biomedical Research Center instituted a multifactorial recruitment and retention strategy, including 1) policies promoting institutionwide cultural competence; 2) study specific recruitment plans implemented by a team of recruiter, public communication specialist, nurse study coordinator, computer specialist, and principal investigator; 3) a management plan using regular team meetings, a computerized tracking system, and volunteer feed back for quality improvement; and 4) reduction of barriers to participation coupled with positive reinforcement incentives. Recruitment methods included 1) radio/television/newsprint ads; 2) presentations at churches, social organizations, and work sites; 3) health fair screening; 4) direct mail; and 5) word of mouth. The results of this strategy are that, in 1995, there were 5456 volunteers for research trials conducted at the Pennington Center, 58% of whom were African Americans.
Although investigators and their immediate research team members may profit from specific recruiting techniques, the commitment of the institution to minority recruitment is an essential element of success.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND: Study of genomic data obtained from patient biospecimens is frequent in research of subjects with prostate and other epithelial malignancies. Understanding of the characteristics of healthy men who participate in genomic research is limited. ## METHODS: Patients were i
Prophylactic therapy is generally used to prevent reactivated hepatitis B after transplantation of an antibody to hepatitis B core antigen (anti-HBc)-positive liver. To gain insight into current practice, a questionnaire was e-mailed to 89 liver transplant physicians in the United States, Europe, an